US Stock MarketDetailed Quotes

SNY Sanofi

Watchlist
  • 48.510
  • +0.500+1.04%
Close Dec 5 16:00 ET
  • 48.440
  • -0.070-0.14%
Pre 04:02 ET
121.62BMarket Cap25.53P/E (TTM)

Sanofi Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(FY)Dec 31, 2022
(FY)Dec 31, 2021
(FY)Dec 31, 2020
(FY)Dec 31, 2019
(FY)Dec 31, 2018
(FY)Dec 31, 2017
(FY)Dec 31, 2016
(FY)Dec 31, 2015
(FY)Dec 31, 2014
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-2.55%10.26B
0.04%10.53B
41.84%10.52B
-3.85%7.42B
39.08%7.72B
-24.83%5.55B
-5.86%7.38B
-5.45%7.84B
15.70%8.29B
9.26%7.17B
Net income from continuing operations
-35.49%5.4B
34.52%8.37B
-49.38%6.22B
346.41%12.29B
-36.04%2.75B
-48.84%4.31B
78.72%8.42B
9.84%4.71B
-2.35%4.29B
18.14%4.39B
Operating gains losses
113.42%69M
-623.94%-514M
99.02%-71M
-3,106.19%-7.25B
77.03%-226M
-926.89%-984M
235.23%119M
-151.16%-88M
102.35%172M
198.84%85M
Depreciation and amortization
40.12%4.79B
2.06%3.42B
-8.72%3.35B
-50.69%3.67B
73.99%7.45B
16.09%4.28B
11.66%3.69B
-22.80%3.3B
30.37%4.28B
-35.62%3.28B
Deferred tax
-67.82%-970M
-62.36%-578M
-61.09%-356M
87.53%-221M
-143.74%-1.77B
20.02%-727M
-67.71%-909M
56.74%-542M
-8.86%-1.25B
-27.75%-1.15B
Other non cash items
33.46%339M
8,366.67%254M
100.48%3M
-257.47%-622M
-179.82%-174M
104.95%218M
-1,022.70%-4.4B
-67.52%-392M
-966.67%-234M
121.09%27M
Change In working capital
208.06%764M
-150.18%-707M
533.54%1.41B
22.43%-325M
67.27%-419M
-970.75%-1.28B
-82.29%147M
-21.33%830M
16.19%1.06B
365.64%908M
-Change in receivables
48.91%-397M
-520.00%-777M
238.06%185M
71.00%-134M
-1,220.00%-462M
93.38%-35M
-414.88%-529M
134.08%168M
-2,365.00%-493M
-115.04%-20M
-Change in inventory
9.39%-840M
-159.66%-927M
39.80%-357M
-8.41%-593M
21.97%-547M
-386.81%-701M
55.83%-144M
30.04%-326M
-5,725.00%-466M
83.33%-8M
-Change in payables and accrued expense
-11.06%402M
0.22%452M
424.42%451M
-49.11%86M
-37.41%169M
-53.21%270M
29.08%577M
85.48%447M
-47.49%241M
470.16%459M
-Change in other working capital
193.39%1.6B
-51.77%545M
257.59%1.13B
-24.94%316M
151.72%421M
-434.98%-814M
-55.08%243M
-69.49%541M
271.70%1.77B
103.85%477M
Cash from discontinued investing activities
-45.08%346M
20.00%630M
32.58%525M
Operating cash flow
-2.55%10.26B
0.04%10.53B
41.84%10.52B
-3.85%7.42B
39.08%7.72B
-24.83%5.55B
-9.84%7.38B
-8.25%8.18B
15.99%8.92B
10.58%7.69B
Investing cash flow
Cash flow from continuing investing activities
-198.80%-6.2B
71.57%-2.08B
-301.66%-7.3B
405.92%3.62B
90.81%-1.18B
-344.27%-12.87B
-15.33%-2.9B
16.61%-2.51B
10.31%-3.01B
-184.97%-3.36B
Net PPE purchase and sale
-181.77%-2.01B
47.84%-713M
-17.34%-1.37B
-106.93%-1.17B
-402.69%-563M
113.09%186M
24.17%-1.42B
26.83%-1.87B
-115.03%-2.56B
-32.63%-1.19B
Net business purchase and sale
-346.15%-3.83B
84.55%-858M
-210.29%-5.55B
1,131.56%5.03B
96.20%-488M
-1,017.03%-12.86B
-170.19%-1.15B
-93.64%-426M
87.23%-220M
-633.19%-1.72B
Net investment purchase and sale
72.54%-134M
-56.91%-488M
-127.01%-311M
-260.53%-137M
72.26%-38M
-124.59%-137M
43.52%-61M
23.94%-108M
75.13%-142M
-3,072.22%-571M
Net other investing changes
-1,331.25%-229M
76.47%-16M
39.82%-68M
-20.21%-113M
-62.07%-94M
77.95%-58M
-155.34%-263M
-17.05%-103M
-168.75%-88M
574.07%128M
Cash from discontinued investing activities
Investing cash flow
-198.80%-6.2B
71.57%-2.08B
-301.66%-7.3B
451.70%3.62B
92.01%-1.03B
-2,114.40%-12.87B
124.23%639M
19.04%-2.64B
5.87%-3.26B
-171.80%-3.46B
Financing cash flow
Cash flow from continuing financing activities
-38.33%-8.05B
17.50%-5.82B
-8.80%-7.06B
-54.66%-6.49B
-206.58%-4.19B
149.78%3.93B
-92.68%-7.9B
-14.62%-4.1B
31.11%-3.58B
-38.25%-5.19B
Net issuance payments of debt
-151.89%-3.14B
55.60%-1.25B
-48.75%-2.8B
-283.91%-1.89B
-105.63%-491M
479.71%8.72B
-200.17%-2.3B
70.36%2.29B
445.13%1.35B
-168.66%-390M
Net common stock issuance
-28.80%-398M
-57.65%-309M
68.34%-196M
-504.58%-619M
116.56%153M
49.86%-924M
29.20%-1.84B
-115.12%-2.6B
-8.04%-1.21B
-76.38%-1.12B
Cash dividends paid
-6.86%-4.45B
-3.99%-4.17B
-1.80%-4.01B
-2.69%-3.94B
-1.62%-3.83B
-1.70%-3.77B
1.30%-3.71B
-1.76%-3.76B
-0.49%-3.69B
-1.04%-3.68B
Net other financing activities
35.35%-64M
-106.25%-99M
-9.09%-48M
-109.52%-44M
76.92%-21M
-75.00%-91M
-62.50%-52M
-60.00%-32M
-150.00%-20M
84.62%-8M
Cash from discontinued financing activities
582.61%111M
-264.29%-23M
-54.84%14M
Financing cash flow
-38.33%-8.05B
17.50%-5.82B
-8.80%-7.06B
-54.66%-6.49B
-206.58%-4.19B
149.78%3.93B
-98.05%-7.9B
-10.80%-3.99B
30.48%-3.6B
-39.02%-5.18B
Net cash flow
Beginning cash position
26.12%12.74B
-27.43%10.1B
47.61%13.92B
36.13%9.43B
-32.86%6.93B
0.41%10.32B
12.30%10.27B
24.62%9.15B
-11.09%7.34B
29.40%8.26B
Current changes in cash
-251.86%-3.99B
168.63%2.63B
-184.18%-3.83B
82.59%4.55B
173.52%2.49B
-3,023.28%-3.39B
-92.55%116M
-23.64%1.56B
314.63%2.04B
-148.59%-950M
Effect of exchange rate changes
-500.00%-32M
-46.67%8M
123.44%15M
-811.11%-64M
800.00%9M
101.35%1M
26.73%-74M
56.47%-101M
-782.35%-232M
143.04%34M
End cash Position
-31.61%8.71B
26.12%12.74B
-27.43%10.1B
47.61%13.92B
36.13%9.43B
-32.86%6.93B
-2.73%10.32B
15.92%10.6B
24.62%9.15B
-11.09%7.34B
Free cash flow
-13.11%7.23B
-1.82%8.33B
58.93%8.48B
-10.00%5.34B
66.05%5.93B
-34.17%3.57B
-11.11%5.42B
-0.76%6.1B
-1.43%6.15B
10.43%6.24B
Currency Unit
EUR
EUR
EUR
EUR
EUR
EUR
EUR
EUR
EUR
EUR
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
Unqualified Opinion with Explanatory Notes
Unqualified Opinion with Explanatory Notes
Unqualified Opinion
Unqualified Opinion
Unqualified Opinion
Unqualified Opinion
Unqualified Opinion
(FY)Dec 31, 2023 (FY)Dec 31, 2022 (FY)Dec 31, 2021 (FY)Dec 31, 2020 (FY)Dec 31, 2019 (FY)Dec 31, 2018 (FY)Dec 31, 2017 (FY)Dec 31, 2016 (FY)Dec 31, 2015 (FY)Dec 31, 2014
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -2.55%10.26B 0.04%10.53B 41.84%10.52B -3.85%7.42B 39.08%7.72B -24.83%5.55B -5.86%7.38B -5.45%7.84B 15.70%8.29B 9.26%7.17B
Net income from continuing operations -35.49%5.4B 34.52%8.37B -49.38%6.22B 346.41%12.29B -36.04%2.75B -48.84%4.31B 78.72%8.42B 9.84%4.71B -2.35%4.29B 18.14%4.39B
Operating gains losses 113.42%69M -623.94%-514M 99.02%-71M -3,106.19%-7.25B 77.03%-226M -926.89%-984M 235.23%119M -151.16%-88M 102.35%172M 198.84%85M
Depreciation and amortization 40.12%4.79B 2.06%3.42B -8.72%3.35B -50.69%3.67B 73.99%7.45B 16.09%4.28B 11.66%3.69B -22.80%3.3B 30.37%4.28B -35.62%3.28B
Deferred tax -67.82%-970M -62.36%-578M -61.09%-356M 87.53%-221M -143.74%-1.77B 20.02%-727M -67.71%-909M 56.74%-542M -8.86%-1.25B -27.75%-1.15B
Other non cash items 33.46%339M 8,366.67%254M 100.48%3M -257.47%-622M -179.82%-174M 104.95%218M -1,022.70%-4.4B -67.52%-392M -966.67%-234M 121.09%27M
Change In working capital 208.06%764M -150.18%-707M 533.54%1.41B 22.43%-325M 67.27%-419M -970.75%-1.28B -82.29%147M -21.33%830M 16.19%1.06B 365.64%908M
-Change in receivables 48.91%-397M -520.00%-777M 238.06%185M 71.00%-134M -1,220.00%-462M 93.38%-35M -414.88%-529M 134.08%168M -2,365.00%-493M -115.04%-20M
-Change in inventory 9.39%-840M -159.66%-927M 39.80%-357M -8.41%-593M 21.97%-547M -386.81%-701M 55.83%-144M 30.04%-326M -5,725.00%-466M 83.33%-8M
-Change in payables and accrued expense -11.06%402M 0.22%452M 424.42%451M -49.11%86M -37.41%169M -53.21%270M 29.08%577M 85.48%447M -47.49%241M 470.16%459M
-Change in other working capital 193.39%1.6B -51.77%545M 257.59%1.13B -24.94%316M 151.72%421M -434.98%-814M -55.08%243M -69.49%541M 271.70%1.77B 103.85%477M
Cash from discontinued investing activities -45.08%346M 20.00%630M 32.58%525M
Operating cash flow -2.55%10.26B 0.04%10.53B 41.84%10.52B -3.85%7.42B 39.08%7.72B -24.83%5.55B -9.84%7.38B -8.25%8.18B 15.99%8.92B 10.58%7.69B
Investing cash flow
Cash flow from continuing investing activities -198.80%-6.2B 71.57%-2.08B -301.66%-7.3B 405.92%3.62B 90.81%-1.18B -344.27%-12.87B -15.33%-2.9B 16.61%-2.51B 10.31%-3.01B -184.97%-3.36B
Net PPE purchase and sale -181.77%-2.01B 47.84%-713M -17.34%-1.37B -106.93%-1.17B -402.69%-563M 113.09%186M 24.17%-1.42B 26.83%-1.87B -115.03%-2.56B -32.63%-1.19B
Net business purchase and sale -346.15%-3.83B 84.55%-858M -210.29%-5.55B 1,131.56%5.03B 96.20%-488M -1,017.03%-12.86B -170.19%-1.15B -93.64%-426M 87.23%-220M -633.19%-1.72B
Net investment purchase and sale 72.54%-134M -56.91%-488M -127.01%-311M -260.53%-137M 72.26%-38M -124.59%-137M 43.52%-61M 23.94%-108M 75.13%-142M -3,072.22%-571M
Net other investing changes -1,331.25%-229M 76.47%-16M 39.82%-68M -20.21%-113M -62.07%-94M 77.95%-58M -155.34%-263M -17.05%-103M -168.75%-88M 574.07%128M
Cash from discontinued investing activities
Investing cash flow -198.80%-6.2B 71.57%-2.08B -301.66%-7.3B 451.70%3.62B 92.01%-1.03B -2,114.40%-12.87B 124.23%639M 19.04%-2.64B 5.87%-3.26B -171.80%-3.46B
Financing cash flow
Cash flow from continuing financing activities -38.33%-8.05B 17.50%-5.82B -8.80%-7.06B -54.66%-6.49B -206.58%-4.19B 149.78%3.93B -92.68%-7.9B -14.62%-4.1B 31.11%-3.58B -38.25%-5.19B
Net issuance payments of debt -151.89%-3.14B 55.60%-1.25B -48.75%-2.8B -283.91%-1.89B -105.63%-491M 479.71%8.72B -200.17%-2.3B 70.36%2.29B 445.13%1.35B -168.66%-390M
Net common stock issuance -28.80%-398M -57.65%-309M 68.34%-196M -504.58%-619M 116.56%153M 49.86%-924M 29.20%-1.84B -115.12%-2.6B -8.04%-1.21B -76.38%-1.12B
Cash dividends paid -6.86%-4.45B -3.99%-4.17B -1.80%-4.01B -2.69%-3.94B -1.62%-3.83B -1.70%-3.77B 1.30%-3.71B -1.76%-3.76B -0.49%-3.69B -1.04%-3.68B
Net other financing activities 35.35%-64M -106.25%-99M -9.09%-48M -109.52%-44M 76.92%-21M -75.00%-91M -62.50%-52M -60.00%-32M -150.00%-20M 84.62%-8M
Cash from discontinued financing activities 582.61%111M -264.29%-23M -54.84%14M
Financing cash flow -38.33%-8.05B 17.50%-5.82B -8.80%-7.06B -54.66%-6.49B -206.58%-4.19B 149.78%3.93B -98.05%-7.9B -10.80%-3.99B 30.48%-3.6B -39.02%-5.18B
Net cash flow
Beginning cash position 26.12%12.74B -27.43%10.1B 47.61%13.92B 36.13%9.43B -32.86%6.93B 0.41%10.32B 12.30%10.27B 24.62%9.15B -11.09%7.34B 29.40%8.26B
Current changes in cash -251.86%-3.99B 168.63%2.63B -184.18%-3.83B 82.59%4.55B 173.52%2.49B -3,023.28%-3.39B -92.55%116M -23.64%1.56B 314.63%2.04B -148.59%-950M
Effect of exchange rate changes -500.00%-32M -46.67%8M 123.44%15M -811.11%-64M 800.00%9M 101.35%1M 26.73%-74M 56.47%-101M -782.35%-232M 143.04%34M
End cash Position -31.61%8.71B 26.12%12.74B -27.43%10.1B 47.61%13.92B 36.13%9.43B -32.86%6.93B -2.73%10.32B 15.92%10.6B 24.62%9.15B -11.09%7.34B
Free cash flow -13.11%7.23B -1.82%8.33B 58.93%8.48B -10.00%5.34B 66.05%5.93B -34.17%3.57B -11.11%5.42B -0.76%6.1B -1.43%6.15B 10.43%6.24B
Currency Unit EUR EUR EUR EUR EUR EUR EUR EUR EUR EUR
Accounting Standards US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP
Audit Opinions Unqualified Opinion -- -- Unqualified Opinion with Explanatory Notes Unqualified Opinion with Explanatory Notes Unqualified Opinion Unqualified Opinion Unqualified Opinion Unqualified Opinion Unqualified Opinion
Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Investment Theme Infectious Disease
Infectious Disease
Intraday+0.66%